type I diabetes

Overview

Type I diabetes, more commonly referred to as type 1 diabetes mellitus (T1D), is a chronic autoimmune disease characterized by immune-mediated destruction of pancreatic beta cells, leading to absolute or near-absolute insulin deficiency and persistent hyperglycemia. It typically presents in childhood or adolescence, but it can occur at any age. Because endogenous insulin production is progressively lost, lifelong Insulin Therapy is required for survival and metabolic control.

Biologically, type I diabetes is associated with autoimmunity, genetic susceptibility, and environmental influences that together drive islet inflammation and beta-cell failure. The disease is also linked to other autoimmune conditions, including autoimmune thyroid disease, coeliac disease, inflammatory bowel diseases, and autoimmune liver disease. In recent research, type I diabetes has been studied not only as a metabolic disorder but also as a heterogeneous immune-mediated condition with distinct age-related endotypes, variable residual insulin production, and important cardiometabolic and psychosocial consequences.

Focus of Latest Publications

Recent publications on type 1 diabetes have focused heavily on glucose monitoring and automated insulin delivery, as well as on patient-centered outcomes and broader epidemiology. One study examined continuous glucose monitor data from diverse populations, including people with type 1 diabetes, to test whether fixed glucose thresholds are optimal for summarizing wearable-device data. Using loss functions based on Wasserstein distance, the authors found that data-driven thresholds varied by population and improved discriminative power and associations with clinical variables compared with standard fixed cutoffs.

Several reports addressed technology-assisted management of type 1 diabetes. An evaluation of the Android Artificial Pancreas System in Brazilians with type 1 diabetes assessed its safety and efficacy, while another paper compared model predictive control algorithms for fully closed-loop systems intended to automate glucose regulation in people with type 1 diabetes. Together, these studies reflect ongoing efforts to refine closed-loop insulin delivery and optimize blood glucose control through algorithmic approaches.

Other recent work has emphasized psychosocial outcomes and quality of life. In a cohort of people with type 1 diabetes, investigators sought to estimate minimal clinically important differences for the Problem Areas in Diabetes scale and its subdimensions, and to identify predictors of worsening diabetes distress over one year. Another study in Finnish adults with type 1 diabetes aimed to characterize demographic change in the prevalent adult population and examine associations between known risk factors, comorbidities, and mortality.

Additional publications have explored disease development and autoimmune clustering. The Environmental Determinants of Diabetes in the Young study investigated whether intake and status of vitamins A and E, including retinol, carotenoids, and tocopherols, were associated with islet autoimmunity and progression to type 1 diabetes. A population-based cohort study in Norway examined the incidence and co-occurrence of type 1 diabetes with other autoimmune diseases in childhood, including inflammatory bowel disease, juvenile idiopathic arthritis, coeliac disease, autoimmune thyroid disease, and autoimmune liver disease, by age and sociodemographic factors.

Key Publications

NEWJul Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions. (Statistics in medicine, 2026, PMID 42380066): "Applications to CGM datasets from diverse populations, including individuals with type 1 diabetes, type 2 diabetes, and normal glycemic control, demonstrate that data-driven thresholds vary by population, improve discriminative power, and yield stronger associations with clinical variables over fixed thresholds."
NEWJul Retinol, Carotenoid, and Tocopherol Intake and Status, and the Risk of Islet Autoimmunity and Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study. (Diabetes/metabolism research and reviews, 2026, PMID 42361128): "To study the associations of dietary intake of A and E vitamins, as well as plasma retinols, carotenoids, and tocopherols in relation to development of islet autoimmunity and progression to T1D."
NEWJun Clinical characteristics, glycemic control & quality of life of patients using Android Artificial Pancreas System (AAPS) in Brazil. (Archives of endocrinology and metabolism, 2026, PMID 42348779): "This study evaluated the safety and efficacy of the Android Artificial Pancreas System (AAPS) in Brazilians with type 1 diabetes mellitus (T1D)."
NEWJun What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort. (Diabetes, obesity & metabolism, 2026, PMID 42283146): "...in people with type 1 diabetes (PwT1D)."
Jun Incidence and co-occurrence of six autoimmune diseases in childhood: a population-based cohort study in Norway. (The Lancet. Child & adolescent health, 2026, PMID 42001894): "We aimed to determine the incidence and co-occurrence of type 1 diabetes, inflammatory bowel disease, juvenile idiopathic arthritis, coeliac disease, autoimmune thyroid disease, and autoimmune liver disease by age and individual-level sociodemographic factors."
Jun Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality-Results From the Finnish Diabetes Control Study FinDiCon. (Diabetes, obesity & metabolism, 2026, PMID 41804200): "The objective was to characterise Finnish adults with type 1 diabetes (T1D) and to explore associations between known risk factors, comorbidities and mortality."
Jun Comparison of model Predictive control (MPC) algorithms to optimise blood glucose in fully closed loop (FCL) systems. (International journal of medical informatics, 2026, PMID 41723939): "...automating glucose regulation for people with Type 1 Diabetes."